Search
Selected Filter
Displaying 11–20 of 347 diseases results
-
Stargardt Disease Research Advances
Retinal Disease Research AdvancesRecent developments in research on Stargardt disease
-
Leber Congenital Amaurosis Research Advances
Retinal Disease Research AdvancesRecent developments in research on Leber congenital amaurosis
-
Eye on the Cure Podcast – Episode 39: Paul Bernstein, MD, PhD
Foundation PodcastsJanuary 20, 2023. Paul Bernstein, MD, PhD, from the Moran Eye Center, University of Utah, and a member of the Foundation’s Scientific Advisory Board talks to host Ben Shaberman about his clinical practice for retinal disease patients
-
Fearless Sister Duo Finding Hope
Beacon StoriesApril LuFriu and Melissa Escobio are sisters and best friends who do just about everything together, including having retinitis pigmentosa (RP).
-
The Retinal Degeneration Fund invests in a $78M Series B for Perceive Biotherapeutics
The Foundation in the NewsThe investment supports the clinical development of two novel programs, both with the aim of being protective against vision loss.
-
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
Eye On the Cure Research NewsThe company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
Eye on the Cure Podcast – Episode 37: Rando Allikmets, PhD
Foundation PodcastsDecember 16, 2022. Rando Allikmets, PhD, talks to host Ben Shaberman.
-
Resourceful Advocate for Research
Beacon StoriesManorthia was diagnosed with retinitis pigmentosa (RP) when she was 22 years old but didn’t start experiencing considerable vision loss until years later. Once she began to notice her vision deteriorating more rapidly, she reached out to the Foundation Fighting Blindness to get involved with the blindness community.
-
SparingVision Receives Authorization to Launch US Clinical Trial for its Cone-Preserving Treatment
Eye On the Cure Research NewsThe emerging therapy is designed to work independent of the mutated gene causing retinitis pigmentosa
-
Opus Genetics to Launch Gene Therapy Clinical Trial for LCA5 Patients
Eye On the Cure Research NewsThe LCA5 gene therapy will be the first emerging Opus treatment to move into a human study
.png)
.png)
.png)
